FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2312565529> ?p ?o ?g. }

• W2312565529 endingPage "364" @default.
• W2312565529 startingPage "351" @default.
• W2312565529 abstract "In 1987, exploratory clinical studies were initiated to determine whether the development of AIDS in HIV-infected individuals might be delayed or prevented by immunization with an inactivated HIV preparation. Preclinical studies had shown the preparation to be safe and immunogenic. Twenty-three patients with biopsy-confirmed persistent generalized lymphadenopathy (CDC III) and two with asymptomatic HIV infection and CD4 lymphocyte counts between 135 and 769/mm3 were studied, of whom eight (32%) had additional HIV-related symptoms. Over a 3-year period, they received a median of eight open-label inoculations of 100 micrograms of inactivated gp 120-depleted HIV-1 Immunogen in incomplete Freund's adjuvant (IFA). Clinical, general laboratory, immunologic, and virologic parameters were followed for up to 6 years. No serious treatment-related adverse experiences were reported, nor was accelerated HIV disease progression seen. Twelve patients developed a delayed-type hypersensitivity response (HIV-DTH) to the immunogen and nine showed fourfold or greater increases in anti-p24 antibody titers. In the follow-up period, 10 of the 25 patients developed AIDS and one with Kaposi's sarcoma (KS) at baseline progressed. Of the 12 patients who became HIV-DTH-responsive, one developed an opportunistic infection (OI), occurring approximately 5 years from study onset, and subsequently died. One additional HIV-DTH responder developed KS. Of the 13 patients who remained HIV-DTH-nonresponsive, nine (69%) progressed to AIDS and seven of these have died. Differences were also observed in terms of HIV-DNA copy number, CD4 percentages, and anti-p24 antibody patterns between the HIV-DTH-responsive and -nonresponsive groups, suggesting a more favorable clinical course in the former. HIV-1 Immunogen in IFA appears to be safe and immunogenic. Further studies are indicated to determine clinical efficacy of the HIV Immunogen as well as the significance of the apparent correlation between HIV-DTH responsivity and a more favorable clinical course." @default.
• W2312565529 created "2016-06-24" @default.
• W2312565529 creator A5000101452 @default.
• W2312565529 creator A5001185990 @default.
• W2312565529 creator A5001624664 @default.
• W2312565529 creator A5005008042 @default.
• W2312565529 creator A5005358222 @default.
• W2312565529 creator A5018954667 @default.
• W2312565529 creator A5028440295 @default.
• W2312565529 creator A5032038324 @default.
• W2312565529 creator A5041232534 @default.
• W2312565529 creator A5059117638 @default.
• W2312565529 creator A5077964014 @default.
• W2312565529 creator A5078130346 @default.
• W2312565529 creator A5086680387 @default.
• W2312565529 date "1996-04-01" @default.
• W2312565529 modified "2023-09-27" @default.
• W2312565529 title "Initial Studies on Active Immunization of HIV-Infected Subjects Using a gp120-Depleted HIV-1 Immunogen: Long-Term Follow-Up" @default.
• W2312565529 cites W1521635132 @default.
• W2312565529 cites W1870000325 @default.
• W2312565529 cites W1965450886 @default.
• W2312565529 cites W1972243538 @default.
• W2312565529 cites W1978406852 @default.
• W2312565529 cites W1990273009 @default.
• W2312565529 cites W2005982584 @default.
• W2312565529 cites W2014741597 @default.
• W2312565529 cites W2015811596 @default.
• W2312565529 cites W2016653952 @default.
• W2312565529 cites W2025820488 @default.
• W2312565529 cites W2053937861 @default.
• W2312565529 cites W2062494656 @default.
• W2312565529 cites W2062934891 @default.
• W2312565529 cites W2085161097 @default.
• W2312565529 cites W2087113983 @default.
• W2312565529 cites W2125753727 @default.
• W2312565529 cites W2134212135 @default.
• W2312565529 cites W2143329914 @default.
• W2312565529 cites W2143663670 @default.
• W2312565529 cites W2300271947 @default.
• W2312565529 cites W4252684946 @default.
• W2312565529 doi "https://doi.org/10.1097/00042560-199604010-00005" @default.
• W2312565529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8601221" @default.
• W2312565529 hasPublicationYear "1996" @default.
• W2312565529 type Work @default.
• W2312565529 sameAs 2312565529 @default.
• W2312565529 citedByCount "55" @default.
• W2312565529 countsByYear W23125655292012 @default.
• W2312565529 countsByYear W23125655292014 @default.
• W2312565529 countsByYear W23125655292015 @default.
• W2312565529 countsByYear W23125655292016 @default.
• W2312565529 countsByYear W23125655292017 @default.
• W2312565529 countsByYear W23125655292018 @default.
• W2312565529 countsByYear W23125655292020 @default.
• W2312565529 countsByYear W23125655292022 @default.
• W2312565529 crossrefType "journal-article" @default.
• W2312565529 hasAuthorship W2312565529A5000101452 @default.
• W2312565529 hasAuthorship W2312565529A5001185990 @default.
• W2312565529 hasAuthorship W2312565529A5001624664 @default.
• W2312565529 hasAuthorship W2312565529A5005008042 @default.
• W2312565529 hasAuthorship W2312565529A5005358222 @default.
• W2312565529 hasAuthorship W2312565529A5018954667 @default.
• W2312565529 hasAuthorship W2312565529A5028440295 @default.
• W2312565529 hasAuthorship W2312565529A5032038324 @default.
• W2312565529 hasAuthorship W2312565529A5041232534 @default.
• W2312565529 hasAuthorship W2312565529A5059117638 @default.
• W2312565529 hasAuthorship W2312565529A5077964014 @default.
• W2312565529 hasAuthorship W2312565529A5078130346 @default.
• W2312565529 hasAuthorship W2312565529A5086680387 @default.
• W2312565529 hasBestOaLocation W23125655291 @default.
• W2312565529 hasConcept C126322002 @default.
• W2312565529 hasConcept C159654299 @default.
• W2312565529 hasConcept C197934379 @default.
• W2312565529 hasConcept C203014093 @default.
• W2312565529 hasConcept C22889606 @default.
• W2312565529 hasConcept C2777863537 @default.
• W2312565529 hasConcept C2777910003 @default.
• W2312565529 hasConcept C2779909307 @default.
• W2312565529 hasConcept C2780801004 @default.
• W2312565529 hasConcept C32611913 @default.
• W2312565529 hasConcept C542903549 @default.
• W2312565529 hasConcept C71924100 @default.
• W2312565529 hasConceptScore W2312565529C126322002 @default.
• W2312565529 hasConceptScore W2312565529C159654299 @default.
• W2312565529 hasConceptScore W2312565529C197934379 @default.
• W2312565529 hasConceptScore W2312565529C203014093 @default.
• W2312565529 hasConceptScore W2312565529C22889606 @default.
• W2312565529 hasConceptScore W2312565529C2777863537 @default.
• W2312565529 hasConceptScore W2312565529C2777910003 @default.
• W2312565529 hasConceptScore W2312565529C2779909307 @default.
• W2312565529 hasConceptScore W2312565529C2780801004 @default.
• W2312565529 hasConceptScore W2312565529C32611913 @default.
• W2312565529 hasConceptScore W2312565529C542903549 @default.
• W2312565529 hasConceptScore W2312565529C71924100 @default.
• W2312565529 hasIssue "4" @default.
• W2312565529 hasLocation W23125655291 @default.
• W2312565529 hasLocation W23125655292 @default.
• W2312565529 hasLocation W23125655293 @default.
• W2312565529 hasOpenAccess W2312565529 @default.

• next